These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 15777339)
1. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339 [TBL] [Abstract][Full Text] [Related]
2. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near? Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831 [TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up. Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845 [TBL] [Abstract][Full Text] [Related]
4. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma. Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259 [TBL] [Abstract][Full Text] [Related]
5. [Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients]. Janíková-Oborilová A; Mayer J; Dvorákova D; Mejstrík P; Navritíl M; Vásová I; Kren L; Matuska M Cas Lek Cesk; 2007; 146(4):374-81; discussion 381-2. PubMed ID: 17491248 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Ha CS; Cabanillas F; Lee MS; Tucker SL; McLaughlin P; Rodriguez MA; Younes A; Romaguera JE; Mesina OM; Cox JD Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):188-93. PubMed ID: 16111588 [TBL] [Abstract][Full Text] [Related]
7. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma. Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208 [TBL] [Abstract][Full Text] [Related]
8. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V; Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786 [TBL] [Abstract][Full Text] [Related]
9. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears. Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113 [TBL] [Abstract][Full Text] [Related]
10. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment. Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma. Mandigers CM; Meijerink JP; van 't Veer MB; Mensink EJ; Raemaekers JM Ann Hematol; 2003 Dec; 82(12):743-9. PubMed ID: 14513290 [TBL] [Abstract][Full Text] [Related]
12. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. Zinzani PL; Pulsoni A; Perrotti A; Soverini S; Zaja F; De Renzo A; Storti S; Lauta VM; Guardigni L; Gentilini P; Tucci A; Molinari AL; Gobbi M; Falini B; Fattori PP; Ciccone F; Alinari L; Martelli M; Pileri S; Tura S; Baccarani M J Clin Oncol; 2004 Jul; 22(13):2654-61. PubMed ID: 15159414 [TBL] [Abstract][Full Text] [Related]
13. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients. Tysarowski A; Fabisiewicz A; Paszkiewicz-Kozik E; Kulik J; Walewski J; Siedlecki JA Acta Biochim Pol; 2007; 54(1):135-42. PubMed ID: 17351675 [TBL] [Abstract][Full Text] [Related]
15. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171 [TBL] [Abstract][Full Text] [Related]
16. Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab. Galimberti S; Guerrini F; Morabito F; Palumbo GA; Di Raimondo F; Papineschi F; Caracciolo F; Fazzi R; Cervetti G; Cuzzocrea A; Petrini M Bone Marrow Transplant; 2003 Jul; 32(1):57-63. PubMed ID: 12815479 [TBL] [Abstract][Full Text] [Related]
17. Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma. Sacchi S; Pozzi S; Marcheselli R; Federico M; Tucci A; Merli F; Orsucci L; Liberati M; Vallisa D; Brugiatelli M; Cancer; 2007 Jul; 110(1):121-8. PubMed ID: 17503433 [TBL] [Abstract][Full Text] [Related]
18. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762 [TBL] [Abstract][Full Text] [Related]
19. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448 [TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Hirt C; Dölken G Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]